Press releases
- Dexcom Announces Upcoming Conference Presentations
- Dexcom Updates First Quarter 2022 Conference Call for April 28, 2022 at 5:30 p.m. Eastern Time
- Dexcom Reports First Quarter 2022 Financial Results
- DexCom Showcases Expanded CGM Portfolio at International ATTD Conference, Offering More Choice to People With Diabetes
- Dexcom Publishes Annual Sustainability Report
- Dexcom Announces Dexcom ONE, the Newest Real-Time Continuous Glucose Monitoring System, to Its Range of Scan-Free and Fingerprick†-Free Devices
- Dexcom Schedules First Quarter 2022 Earnings Release and Conference Call for April 28, 2022 at 4:30 p.m. Eastern Time
- Dexcom Announces Four-for-One Forward Stock Split
- Dexcom G7 Receives CE Mark – Next-Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management
- Ontario Announces Public Coverage for the Dexcom G6 Continuous Glucose Monitoring System under the Assistive Devices Program
More ▼
Key statistics
On Tuesday, Dexcom Inc (0A4M:LSE) closed at 327.66, 7.56% above its 52-week low of 304.63, set on May 12, 2022.
52-week range
Markit short selling activity
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | 552.40 |
Previous close | 327.66 |
Average volume | 940.38 |
---|---|
Shares outstanding | 98.13m |
Free float | 97.73m |
P/E (TTM) | 163.72 |
Market cap | 32.85bn USD |
EPS (TTM) | 2.04 USD |
Data delayed at least 20 minutes, as of May 17 2022 18:01 BST.
More ▼